MARKET INTRODUCTION
Angiotensin is a chemical in body that narrows the blood vessels. This narrowing can increase blood pressure and force the heart to work harder. Angiotensin II receptor blockers help relax the veins and arteries to lower blood pressure and make it easier for heart to pump blood. Angiotensin II receptor blockers block the action of angiotensin II. As a result, the medication allows your veins and arteries to widen (dilate).
MARKET DYNAMICS
Increasing incidence of target diseases such as hypertension, kidney failure from diabetes, across the globe coupled with rising geriatric population is expected to stimulate market growth. For instance, according to American Heart Association statistics 2020, more than 103 million individuals in U.S. suffer from high blood pressure. However, associated side effects (such as severe dizziness, higher than normal potassium levels in the blood (hyperkalemia), swelling of the skin due to a buildup of fluid (angioedema) and drug recalls are the major hindrance for market growth.
MARKET SCOPE
The "Global Angiotensin II Receptor Blockers Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Angiotensin II Receptor Blockers Market with detailed market segmentation by type, application, and geography. The Global Angiotensin II Receptor Blockers Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Angiotensin II Receptor Blockers Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Angiotensin II Receptor Blockers Market is segmented on the basis of type, and application. On the basis of type, market can be classified as azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan. Based on application the market is segmented into hypertension, cardiovascular risks, kidney failure in diabetes, chronic kidney diseases.
.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Angiotensin II Receptor Blockers Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Angiotensin II Receptor Blockers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Angiotensin II Receptor Blockers Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Angiotensin II Receptor Blockers Market in these regions.

MARKET PLAYERS
The report covers key developments in the Angiotensin II Receptor Blockers Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Angiotensin II Receptor Blockers Market are anticipated to lucrative growth opportunities in the future with the rising demand for Angiotensin II Receptor Blockers Market in the global market. Below mentioned is the list of few companies engaged in the Angiotensin II Receptor Blockers Market.
The report also includes the profiles of key Angiotensin II Receptor Blockers Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca
- Daichii Sankyo
- Novartis
- Abbvie
- Lupin
- Takeda
- Zydus Cadila
- Sun Pharmaceutical
- Abbott Laboratories
- ALEMBIC PHARMS LTD.
- MYLAN
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.